Eterna Therapeutics
ERNA
#11154
Rank
โ‚ฌ2.51 M
Marketcap
1,49ย โ‚ฌ
Share price
0.62%
Change (1 day)
23.44%
Change (1 year)

Earnings for Eterna Therapeutics (ERNA)

Earnings in 2026 (TTM): -โ‚ฌ14.22 Million

According to Eterna Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ12.87 Million, an increase over its 2024 earnings that were of -โ‚ฌ34.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eterna Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ14.22 Million10.5%
2025 -โ‚ฌ12.87 Million-62.78%
2024 -โ‚ฌ34.56 Million84.63%
2023 -โ‚ฌ18.72 Million-16.24%
2022 -โ‚ฌ22.35 Million-80.08%
2021 -โ‚ฌ0.12 Billion1596.7%
2020 -โ‚ฌ6.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
โ‚ฌ7.10 B-47,243.04%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-โ‚ฌ0.18 Billion 1,031.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
โ‚ฌ14.57 M-196.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚ฌ17.37 Million 15.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-โ‚ฌ3.53 Million-76.61%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.11 B-7,509.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
โ‚ฌ0.22 B-1,615.19%๐Ÿ‡บ๐Ÿ‡ธ USA